Centrus Energy Corp vs Philip Morris International Inc. — how do they compare? Centrus Energy Corp trades at $190.59 (market cap $3.77B), while Philip Morris International Inc. trades at $185.85 (market cap $290.24B). The key difference: Philip Morris International Inc. is far larger — about 77× Centrus Energy Corp's market cap, and Philip Morris International Inc. pays a 3.16% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.
| LEU | PM | |
|---|---|---|
Market Cap | $3.77B | $290.24B |
Sector | Energy | Consumer Staples |
52-Week High | $436.00 | $200.17 |
52-Week Low | $146.61 | $144.33 |
Enterprise Value | $3.08B | $333.36B |
Dividend Yield | — | 3.16% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $186.22, down 1.77% with mixed technical signals. The company reported strong Q1 and Q2 2026 earnings beats but faces margin pressure from rising costs. Revenue grew to $40.65B in 2025 with a robust 25.56% net income margin. Analyst consensus remains bullish with a $211.17 price target, though recent news highlights challenges including a $500M impairment charge and increased illicit cigarette trade in Europe.
PM offers solid fundamentals with high profitability and dividend yield, but near-term headwinds from cost inflation and regulatory risks warrant caution. The stock's valuation at 25.54x P/E is reasonable given earnings growth potential, making it attractive for long-term investors despite current volatility.
Trailing returns across standard periods
Latest headlines on both assets
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →